Molecular Oncology
Volume 1, Issue 2 , Pages 172-180 , September 2007

Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications

Received 14 February 2007 ,Revised 26 March 2007 ,Accepted 28 March 2007.

References 

  1. Baban D, Matsumura Y, Kocialkowski S, Tarin D. Studies on relationships between metastatic and non-metastatic tumor cell populations using lineages labeled with dominant selectable genetic markers. Int. J. Dev. Biol. 1993;37(1):237–243
  2. Bao L, Pigott R, Matsumura Y, Baban D, Tarin D. Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines. Differentiation. 1993;52(3):239–246
  3. Bernards R, Weinberg RA. A progression puzzle. Nature. 2002;418(6900):823
  4. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer. 1957;11(3):359–377
  5. Feng Y, Sun B, Li X, et al. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res. Treat. 2006;Available from: www.springerlink.com(PMID number 17123152)
  6. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science. 1977;197(4306):893–895
  7. Hampton T. Breast cancer gene chip study under way: can new technology help predict treatment success?. JAMA. 2004;291(24):2927–2930
  8. Hao X, Sun B, Hu L, et al. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer. 2004;100(6):1110–1122
  9. Jenssen TK, Hovig E. Gene-expression profiling in breast cancer. Lancet. 2005;365(9460):634–635
  10. Kallioniemi O. Medicine: profile of a tumour. Nature. 2004;428(6981):379–382
  11. Kripke ML, Gruys E, Fidler IJ. Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res. 1978;38(9):2962–2967
  12. Lahdesmaki H, Hao X, Sun B, et al. Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis. Int. J. Oncol. 2004;24(6):1589–1596
  13. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA. 2001;98(1):31–36
  14. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2001;2:(RESEARCH 0032, Epub)
  15. Moffett BF, Baban D, Bao L, Tarin D. Fate of clonal lineages during neoplasia and metastasis studied with an incorporated genetic marker. Cancer Res. 1992;52(7):1737–1743
  16. Montel V, Pestonjamasp K, Mose E, Tarin D. Tumor-host interactions contribute to the elevated expression level of alpha1-antichymotrypsin in metastatic breast tumor xenografts. Differentiation. 2005;73(2–3):88–98
  17. Montel V, Huang TY, Mose E, Pestonjamasp K, Tarin D. Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am. J. Pathol. 2005;166(5):1565–1579
  18. Montel V, Kleeman J, Agarwal D, Spinella D, Kawai K, Tarin D. Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Res. 2004;64(5):1687–1694
  19. Montel V, Mose ES, Tarin D. Tumor–stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. Int. J. Cancer. 2006;119:251–263
  20. Nicolson GL, Brunson KW, Fidler IJ. Specificity of arrest, survival, and growth of selected metastatic variant cell lines. Cancer Res. 1978;38(11 Pt 2):4105–4111
  21. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571–573
  22. Poste G, Doll J, Fidler IJ. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc. Natl. Acad. Sci. USA. 1981;78(10):6226–6230
  23. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 2003;33(1):49–54
  24. Stuart RO, Wachsman W, Berry CC, et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc. Natl. Acad. Sci. USA. 2004;101(2):615–620
  25. Tarin D. Tumor Metastasis. In:  McGee J,  Isaacson PG,  Wright N editor. Principles of Pathology. Oxford Textbook of Pathology. vol. 1:Oxford: Oxford University Press; 1992;p. 607–633
  26. Tarin D, Price JE. Influence of microenvironment and vascular anatomy on “metastatic” colonization potential of mammary tumors. Cancer Res. 1981;41(9 Pt 1):3604–3609
  27. Tarin D, Price JE, Kettlewell MG, Souter RG, Vass AC, Crossley B. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res. 1984;44(8):3584–3592
  28. Urquidi V, Sloan D, Kawai K, et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin. Cancer Res. 2002;8(1):61–74
  29. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 2002;347(25):1999–2009
  30. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530–536
  31. Wang Y, Klijn JG, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005;365(9460):671–679
  32. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc. Natl. Acad. Sci. USA. 2003;100(26):15901–15905
  33. Weigelt B, Wessels LF, Bosma AJ, et al. No common denominator for breast cancer lymph node metastasis. Br. J. Cancer. 2005;93(8):924–932
  34. Weigelt B, Hu Z, He X, et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 2005;65(20):9155–9158

PII: S1574-7891(07)00015-4

doi: 10.1016/j.molonc.2007.03.005

Molecular Oncology
Volume 1, Issue 2 , Pages 172-180 , September 2007

Article Tools

* Image Usage & Resolution